Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cellebrite DI Lowers FY2025 Sales Guidance from $480.00M-$490.00M to $470.00M-$485.00M vs $484.17M Est

Author: Benzinga Newsdesk | May 14, 2025 06:02am
Cellebrite DI (NASDAQ:CLBT) lowers FY2025 sales outlook from $480.00 million-$490.00 million to $470.00 million-$485.00 million vs $484.17 million estimate.

Posted In: CLBT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist